Status:
COMPLETED
Corticosteroid Nasal Spray in COVID-19 Anosmia
Lead Sponsor:
Benha University
Conditions:
Covid19
Anosmia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The aim of this study is to evaluate the role of the topical corticosteroids nasal spray (mometasone furoate nasal spray) in improving anosmia in patients recovered from COVID-19 infection.
Detailed Description
This study willbe submitted on patients who recently recovered from proven COVID-19 infection and complaining of anosmia or hyposmia.The proven COVID-19 infection will be relied on a positive real-tim...
Eligibility Criteria
Inclusion
- adults 18 yrs or older patients
- confirmed case (+ve PCR),
- recovered/discharged (2 -ve PCR),
- suffered from sudden recent anosmia or hyposmia
Exclusion
- patients already on nasal steroid
- with previous chronic rhinological pathologies,
- patients on systemic steroid for previous systemic disease,
- anosmia improved before COVID19 recovery,
- pregnancy
- patients who will not complete the follow up period.
Key Trial Info
Start Date :
August 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04484493
Start Date
August 8 2020
End Date
November 3 2020
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha University Hospital, Faculty of Medicine
Banhā, Qalyubia Governorate, Egypt, 13512